A role of the inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents

Diabetes

Volumn 65, Issue 3, 2016, Pages 610-618

  Kursawe, Romy ^a   Dixit, Vishwa D ^a   Scherer, Philipp E ^b   Santoro, Nicola ^a   Narayan, Deepak ^a   Gordillo, Ruth ^b   Giannini, Cosimo ^a   Lopez, Ximena ^b   Pierpont, Bridget ^a   Nouws, Jessica ^a   Shulman, Gerald I ^a,c   Caprio, Sonia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CRYOPYRIN; GLUCOSE TRANSPORTER 4; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TOLL LIKE RECEPTOR 4; ACACA PROTEIN, HUMAN; ACETYL COENZYME A CARBOXYLASE; ADIPOQ PROTEIN, HUMAN; CARRIER PROTEIN; FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE; IL1B PROTEIN, HUMAN; LEPTIN; LIPOPROTEIN LIPASE; LPL PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN; SREBF1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TLR4 PROTEIN, HUMAN;

ABDOMINAL FAT; ABDOMINAL SUBCUTANEOUS FAT; ADIPOGENESIS; ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; CELL INFILTRATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ABDOMEN; CHILD; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; INSULIN RESISTANCE; LIPOGENESIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGY; SUBCUTANEOUS FAT;

ABDOMEN; ACETYL-COA CARBOXYLASE; ADIPOGENESIS; ADIPONECTIN; ADOLESCENT; CARRIER PROTEINS; CASPASE 1; CHILD; DOWN-REGULATION; FATTY ACID SYNTHASE, TYPE I; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INFLAMMASOMES; INSULIN RESISTANCE; INTERLEUKIN-1BETA; INTRA-ABDOMINAL FAT; LEPTIN; LIPOGENESIS; LIPOPROTEIN LIPASE; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; OBESITY; PPAR GAMMA; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUBCUTANEOUS FAT; TOLL-LIKE RECEPTOR 4;

EID: 84962433778     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1478     Document Type: Article

References (33)

1. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246
2. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
3. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124
4. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946
5. Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 2011; 108:15324-15329
6. Stienstra R, Joosten LA, Koenen T, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 2010;12:593-605
7. Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A, Dixit VD. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 2011;152:4039-4045
8. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17:179-188
9. Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011;12:408-415
10. Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010;327:296-300
11. Kursawe R, Eszlinger M, Narayan D, et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010;59:2288-2296
12. Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008;57:367-371
13. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. 1999;22:1462-1470
14. Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009;49:1896-1903
15. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 2008;59:521-527
16. Holland WL, Miyauchi Y, Gordillo R, Scherer PE. Sphingolipid profiling of adipose tissue: specific overexpression of ceramidase improves whole body glucose and lipid metabolism. Late-breaking poster presented at the ASMS 61st Conference on Mass Spectrometry and Allied Topics, 9-13 June 2013, Minneapolis, Minnesota
17. Gillum MP, Kotas ME, Erion DM, et al. SirT1 regulates adipose tissue inflammation. Diabetes 2011;60:3235-3245
18. Grant RW, Dixit VD. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front Immunol 2013;4:50
19. Lagathu C, Yvan-Charvet L, Bastard JP, et al. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 2006;49:2162-2173
20. Esser N, L'homme L, De Roover A, et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 2013;56:2487-2497
21. Goossens GH, Blaak EE, Theunissen R, et al. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol Immunol 2012;50:142-149
22. Chalkiadaki A, Guarente L. High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab 2012;16:180-188
23. Adams JM 2nd, Pratipanawatr T, Berria R, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004;53:25-31
24. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006;55:2579-2587
25. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998;95: 2498-2502
26. Kabayama K, Sato T, Kitamura F, et al. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 2005;15:21-29
27. Holland WL, Bikman BT, Wang LP, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011;121:1858-1870
28. Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab 2013;26:995-998
29. Majumdar I, Mastrandrea LD. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 2012;41:442-449
30. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008;283:13538-13548
31. Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Obesity (Silver Spring) 2012;20:2341-2347
32. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56:1960-1968
33. Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med 2010;16:400-402